Prot # RFHE4044: A Multicenter, Randomized, Open-Label, Active-Controlled, Trial to Evaluate the Safety and Efficacy of Rifaximin 550 mg with and Without Lactulose in Subjects with a History of Recurrent Overt Hepatic Encephalopathy